Design Therapeutics Eulerpool Nieuws

Design Therapeutics Aandeel Nieuws

Design Therapeutics wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Design Therapeutics nieuwsberichten verzamelen we hier.

• 4 juni ·

  Yahoo
  Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2
• 28 mei ·

  Yahoo
  Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
• 13 mei ·

  Yahoo
  Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
• 2 mei ·

  Yahoo
  Design Therapeutics reports positive outcomes from trial of DT-168 eye drops
• 1 mei ·

  Yahoo
  Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy
• 18 april ·

  Yahoo
  April 2025's Promising Penny Stocks
• 17 april ·

  Yahoo
  Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
• 17 april ·

  Yahoo
  Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
• 22 januari ·

  Yahoo
  3 Promising US Penny Stocks With Market Caps Under $900M
• 21 januari ·

  SeekingAlpha
  Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart